Startseite » Research » Research areas » Psychotherapy » Clinical psychology and psychotherapy

Clinical psychology and psychotherapy


Dr. Dipl.-Psych. phil. Annette Schaub

The Working Group on Clinical Psychology and Psychotherapy is dedicated to studying psychiatric disorders and their treatment. We focus on the implementation and evaluation of group programmes in schizophrenia, unipolar depression and bipolar disorders and on the integration of patients’ relatives into treatment. In the last 20 years, programmes that view individuals as capable of taking an active role in managing their illness have gained importance in Europe and the U.S. The implementation of group format psychoeducational coping-oriented treatment programmes, which provide information about the illness and its treatment and are based on the stress vulnerability model, was the first step to establish cognitive behavioural therapy and dispel the myths about schizophrenia and affective disorders (Schaub, Hippius, Möller, Falkai, 2016). In addition, topics such as establishing rewarding activities, stress management, cognitive therapy and relapse prevention were offered. Three different group programmes for schizophrenia and affective disorders (see wards B2, B3 and C1 ) were implemented and psychoeducational groups were provided for relatives (Schaub, Mueser, von Werder et al. 2016; Schaub, Roth and Goldman, 2013; Schaub und Frank 2010).

We treated 196 patients with schizophrenia and 177 patients with depression in psychoeducational and cognitive behavioural group treatment programmes and evaluated the programmes in randomised, controlled, 2-year follow-up studies. Participants’ knowledge about their illness and its treatment increased, as did their skills in managing their illness and their satisfaction with treatment. The course of the illness was less severe in the psychotherapeutic group than in the control group. Individuals with severe mental illnesses can benefit from psychoeducational and cognitive treatment programmes if the programmes are adapted to the person’s level of neuropsychological functioning and compensate for cognitive deficits and emotional overload (Schaub, Neubauer, Mueser et al., 2013). These findings suggest that providing patients and relatives with information about the illness and coping skills is important for treatment outcome.


Munich Symposium for Psychiatry and Psychotherapy: Understanding and Treating Cognition and Depression in Schizophrenia and Affective Disorders. October 6th in 2018 (Dr. A. Schaub, PhD, and Prof. P. Falkai)
Speakers include Prof. Fowler, Prof. Miklowitz, Prof. Mueser, Prof. Nuechterlein, Prof. Torrent and Prof. Vinogradov


The study about cognitive psychoeducational behavioural therapy in depression (principal investigator A.S.) was supported by the German Research Network on Depression, which was initiated by Profs. U Hegerl, HJ Möller and F Holsboer, and was funded by the German Federal Ministry for Education and Research (BMBF, no.: 01G10219) for five years.

The study about the coping-orientated treatment programme in schizophrenia (principal investigator A.S.) was supported by the Eli Lilly International Foundation (grant number Eli 8265044; principal investigator A.S.) and Lilly Homburg GmbH Deutschland for five years.


This link will take you to an overview of the most important publications of the Working Group on Clinical Psychology and Psychotherapy.


  • Kim T. Mueser, University of Boston, USA
  • Keith Nuechterlein, University of California, Los Angeles, USA
  • P. Garety, King’s College London, UK
  • D. Fowler, Sussex, UK
  • P. McGorry, University of Melbourne, Australia